Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer

• Status: Completed
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

For patients resistant to enthrycycline and taxanes, there is no standard regimen. Pemetrexed alone had certain efficacy in treatment of advance breast cancer. Platin was also a effective drug for advanced breast cancer. The combination of these two drug may have a synergy with each other in treatment of advanced breast cancer.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese Academy of Medical Sciences
• Treatments: Cisplatin; Pemetrexed

Criteria

Inclusion Criteria:

• 18-70 years old

• Resistant to enthracycle and taxanes

• Has measurable disease

Exclusion Criteria:

• Has more than 3 previous chemotherapy regimens